GME — Geratherm Medical AG Balance Sheet
0.000.00%
- €18.62m
- €11.38m
- €13.98m
- 84
- 79
- 54
- 88
Annual balance sheet for Geratherm Medical AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.3 | 6.47 | 10.9 | 7.74 | 9.64 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.46 | 3.18 | 3.78 | 1.81 | 1.19 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21.4 | 18.9 | 23.6 | 21 | 18.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.68 | 8.78 | 9.99 | 9.45 | 7.67 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 36 | 32.6 | 38.4 | 35.7 | 28.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.83 | 4.09 | 8 | 6.6 | 6.53 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.7 | 14.6 | 16 | 13.4 | 7.52 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 20.3 | 18 | 22.3 | 22.3 | 21 |
| Total Liabilities & Shareholders' Equity | 36 | 32.6 | 38.4 | 35.7 | 28.5 |
| Total Common Shares Outstanding |